nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—cervical cancer—ovarian cancer	0.282	1	CtDrD
Topotecan—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.2	0.519	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.185	0.481	CiPCiCtD
Topotecan—TOP1—ovarian cancer	0.18	0.893	CbGaD
Topotecan—ABCB1—ovarian cancer	0.0215	0.106	CbGaD
Topotecan—ABCG2—Paclitaxel—ovarian cancer	0.0138	0.188	CbGbCtD
Topotecan—ABCG2—Carboplatin—ovarian cancer	0.013	0.177	CbGbCtD
Topotecan—ABCG2—Docetaxel—ovarian cancer	0.00996	0.136	CbGbCtD
Topotecan—ABCG2—Doxorubicin—ovarian cancer	0.00743	0.101	CbGbCtD
Topotecan—ABCB1—Vinorelbine—ovarian cancer	0.00707	0.0963	CbGbCtD
Topotecan—ABCB1—Paclitaxel—ovarian cancer	0.00497	0.0677	CbGbCtD
Topotecan—CYP3A4—Vinorelbine—ovarian cancer	0.00424	0.0577	CbGbCtD
Topotecan—ABCB1—Docetaxel—ovarian cancer	0.00359	0.0489	CbGbCtD
Topotecan—CYP3A4—Paclitaxel—ovarian cancer	0.00298	0.0406	CbGbCtD
Topotecan—ABCB1—Doxorubicin—ovarian cancer	0.00268	0.0365	CbGbCtD
Topotecan—CYP3A4—Docetaxel—ovarian cancer	0.00215	0.0293	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—ovarian cancer	0.0016	0.0219	CbGbCtD
Topotecan—Irinotecan—TOP1—ovarian cancer	0.00135	0.893	CrCbGaD
Topotecan—TOP1MT—gonad—ovarian cancer	0.000939	0.0815	CbGeAlD
Topotecan—TOP1MT—female reproductive system—ovarian cancer	0.000838	0.0728	CbGeAlD
Topotecan—TOP1MT—female gonad—ovarian cancer	0.000763	0.0663	CbGeAlD
Topotecan—TOP1—myometrium—ovarian cancer	0.000759	0.0659	CbGeAlD
Topotecan—TOP1MT—testis—ovarian cancer	0.000677	0.0588	CbGeAlD
Topotecan—TOP1—uterine cervix—ovarian cancer	0.00059	0.0513	CbGeAlD
Topotecan—TOP1—decidua—ovarian cancer	0.000562	0.0488	CbGeAlD
Topotecan—TOP1—endometrium—ovarian cancer	0.000534	0.0464	CbGeAlD
Topotecan—TOP1—uterus—ovarian cancer	0.000492	0.0427	CbGeAlD
Topotecan—TOP1MT—lymph node—ovarian cancer	0.00049	0.0426	CbGeAlD
Topotecan—TOP1—bone marrow—ovarian cancer	0.000418	0.0363	CbGeAlD
Topotecan—TOP1—female gonad—ovarian cancer	0.000402	0.035	CbGeAlD
Topotecan—TOP1—vagina—ovarian cancer	0.0004	0.0347	CbGeAlD
Topotecan—TOP1—testis—ovarian cancer	0.000357	0.031	CbGeAlD
Topotecan—ABCG2—myometrium—ovarian cancer	0.000269	0.0234	CbGeAlD
Topotecan—TOP1—lymph node—ovarian cancer	0.000259	0.0225	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—XIAP—ovarian cancer	0.00024	0.0649	CbGpPWpGaD
Topotecan—ABCG2—uterine cervix—ovarian cancer	0.000209	0.0182	CbGeAlD
Topotecan—ABCG2—Abacavir transmembrane transport—ABCB1—ovarian cancer	0.0002	0.054	CbGpPWpGaD
Topotecan—ABCG2—decidua—ovarian cancer	0.0002	0.0173	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—PARP1—ovarian cancer	0.000199	0.0538	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFSF10—ovarian cancer	0.000196	0.0531	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000195	0.0527	CbGpPWpGaD
Topotecan—ABCG2—endometrium—ovarian cancer	0.000189	0.0165	CbGeAlD
Topotecan—ABCG2—uterus—ovarian cancer	0.000175	0.0152	CbGeAlD
Topotecan—Irinotecan—ABCB1—ovarian cancer	0.000161	0.106	CrCbGaD
Topotecan—ABCG2—bone marrow—ovarian cancer	0.000148	0.0129	CbGeAlD
Topotecan—ABCG2—female gonad—ovarian cancer	0.000143	0.0124	CbGeAlD
Topotecan—ABCG2—vagina—ovarian cancer	0.000142	0.0123	CbGeAlD
Topotecan—TOP1—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000133	0.0361	CbGpPWpGaD
Topotecan—ABCB1—myometrium—ovarian cancer	0.000133	0.0115	CbGeAlD
Topotecan—ABCB1—embryo—ovarian cancer	0.000128	0.0111	CbGeAlD
Topotecan—ABCG2—testis—ovarian cancer	0.000127	0.011	CbGeAlD
Topotecan—TOP1—Circadian rythm related genes—HNF1B—ovarian cancer	0.000115	0.0313	CbGpPWpGaD
Topotecan—ABCG2—Abacavir transport and metabolism—ABCB1—ovarian cancer	0.000115	0.031	CbGpPWpGaD
Topotecan—CYP3A4—female reproductive system—ovarian cancer	0.000109	0.00949	CbGeAlD
Topotecan—ABCB1—epithelium—ovarian cancer	0.000104	0.00905	CbGeAlD
Topotecan—ABCB1—uterine cervix—ovarian cancer	0.000103	0.00897	CbGeAlD
Topotecan—ABCB1—decidua—ovarian cancer	9.84e-05	0.00855	CbGeAlD
Topotecan—ABCB1—endometrium—ovarian cancer	9.34e-05	0.00811	CbGeAlD
Topotecan—ABCG2—lymph node—ovarian cancer	9.18e-05	0.00797	CbGeAlD
Topotecan—ABCB1—gonad—ovarian cancer	8.66e-05	0.00752	CbGeAlD
Topotecan—ABCB1—uterus—ovarian cancer	8.61e-05	0.00748	CbGeAlD
Topotecan—ABCB1—female reproductive system—ovarian cancer	7.74e-05	0.00672	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—CASP3—ovarian cancer	7.61e-05	0.0206	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	7.59e-05	0.0205	CbGpPWpGaD
Topotecan—ABCB1—bone marrow—ovarian cancer	7.3e-05	0.00634	CbGeAlD
Topotecan—ABCB1—female gonad—ovarian cancer	7.04e-05	0.00611	CbGeAlD
Topotecan—ABCB1—vagina—ovarian cancer	7e-05	0.00608	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	6.93e-05	0.0188	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	6.5e-05	0.0176	CbGpPWpGaD
Topotecan—ABCG2—Irinotecan Pathway—APC—ovarian cancer	6.31e-05	0.0171	CbGpPWpGaD
Topotecan—ABCB1—testis—ovarian cancer	6.24e-05	0.00542	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	5.88e-05	0.0159	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	5.69e-05	0.0154	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	5.69e-05	0.0154	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	5.59e-05	0.0151	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—ovarian cancer	5.45e-05	0.0148	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TYMS—ovarian cancer	5.36e-05	0.0145	CbGpPWpGaD
Topotecan—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	5.09e-05	0.0138	CbGpPWpGaD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	5.04e-05	0.0137	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	4.79e-05	0.013	CbGpPWpGaD
Topotecan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	4.56e-05	0.0124	CbGpPWpGaD
Topotecan—ABCB1—lymph node—ovarian cancer	4.53e-05	0.00393	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4.34e-05	0.0117	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TYMS—ovarian cancer	4.33e-05	0.0117	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	4.29e-05	0.0116	CbGpPWpGaD
Topotecan—Haemorrhage—Docetaxel—ovarian cancer	4.24e-05	0.001	CcSEcCtD
Topotecan—Hypoaesthesia—Docetaxel—ovarian cancer	4.22e-05	0.000998	CcSEcCtD
Topotecan—Lethargy—Epirubicin—ovarian cancer	4.22e-05	0.000998	CcSEcCtD
Topotecan—Back pain—Paclitaxel—ovarian cancer	4.21e-05	0.000997	CcSEcCtD
Topotecan—Pharyngitis—Docetaxel—ovarian cancer	4.21e-05	0.000996	CcSEcCtD
Topotecan—Urticaria—Vinorelbine—ovarian cancer	4.2e-05	0.000993	CcSEcCtD
Topotecan—Muscle spasms—Paclitaxel—ovarian cancer	4.19e-05	0.000991	CcSEcCtD
Topotecan—Body temperature increased—Vinorelbine—ovarian cancer	4.18e-05	0.000988	CcSEcCtD
Topotecan—Abdominal pain—Vinorelbine—ovarian cancer	4.18e-05	0.000988	CcSEcCtD
Topotecan—Diarrhoea—Melphalan—ovarian cancer	4.14e-05	0.000979	CcSEcCtD
Topotecan—Nausea—Chlorambucil—ovarian cancer	4.12e-05	0.000975	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—ovarian cancer	4.12e-05	0.0111	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	4.1e-05	0.0111	CbGpPWpGaD
Topotecan—Ill-defined disorder—Paclitaxel—ovarian cancer	4.04e-05	0.000956	CcSEcCtD
Topotecan—Anaemia—Paclitaxel—ovarian cancer	4.03e-05	0.000952	CcSEcCtD
Topotecan—Dermatitis bullous—Doxorubicin—ovarian cancer	4e-05	0.000947	CcSEcCtD
Topotecan—Angioedema—Paclitaxel—ovarian cancer	3.98e-05	0.000942	CcSEcCtD
Topotecan—Anaphylactoid reaction—Doxorubicin—ovarian cancer	3.95e-05	0.000935	CcSEcCtD
Topotecan—Cardiac arrest—Epirubicin—ovarian cancer	3.93e-05	0.00093	CcSEcCtD
Topotecan—Malaise—Paclitaxel—ovarian cancer	3.93e-05	0.000929	CcSEcCtD
Topotecan—Lethargy—Doxorubicin—ovarian cancer	3.9e-05	0.000924	CcSEcCtD
Topotecan—Leukopenia—Paclitaxel—ovarian cancer	3.9e-05	0.000922	CcSEcCtD
Topotecan—Hypersensitivity—Vinorelbine—ovarian cancer	3.89e-05	0.000921	CcSEcCtD
Topotecan—Angiopathy—Docetaxel—ovarian cancer	3.85e-05	0.00091	CcSEcCtD
Topotecan—Vomiting—Melphalan—ovarian cancer	3.85e-05	0.00091	CcSEcCtD
Topotecan—Immune system disorder—Docetaxel—ovarian cancer	3.83e-05	0.000906	CcSEcCtD
Topotecan—Mediastinal disorder—Docetaxel—ovarian cancer	3.82e-05	0.000904	CcSEcCtD
Topotecan—Rash—Melphalan—ovarian cancer	3.81e-05	0.000902	CcSEcCtD
Topotecan—Dermatitis—Melphalan—ovarian cancer	3.81e-05	0.000902	CcSEcCtD
Topotecan—Chills—Docetaxel—ovarian cancer	3.8e-05	0.0009	CcSEcCtD
Topotecan—Cough—Paclitaxel—ovarian cancer	3.8e-05	0.000899	CcSEcCtD
Topotecan—Asthenia—Vinorelbine—ovarian cancer	3.79e-05	0.000897	CcSEcCtD
Topotecan—Alopecia—Docetaxel—ovarian cancer	3.75e-05	0.000887	CcSEcCtD
Topotecan—Pruritus—Vinorelbine—ovarian cancer	3.74e-05	0.000885	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	3.72e-05	0.000881	CcSEcCtD
Topotecan—Arthralgia—Paclitaxel—ovarian cancer	3.71e-05	0.000877	CcSEcCtD
Topotecan—Myalgia—Paclitaxel—ovarian cancer	3.71e-05	0.000877	CcSEcCtD
Topotecan—Chest pain—Paclitaxel—ovarian cancer	3.71e-05	0.000877	CcSEcCtD
Topotecan—Malnutrition—Docetaxel—ovarian cancer	3.69e-05	0.000873	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	3.68e-05	0.000871	CcSEcCtD
Topotecan—Discomfort—Paclitaxel—ovarian cancer	3.66e-05	0.000867	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Epirubicin—ovarian cancer	3.65e-05	0.000863	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—ovarian cancer	3.64e-05	0.000861	CcSEcCtD
Topotecan—Diarrhoea—Vinorelbine—ovarian cancer	3.62e-05	0.000856	CcSEcCtD
Topotecan—Nausea—Melphalan—ovarian cancer	3.59e-05	0.00085	CcSEcCtD
Topotecan—Back pain—Docetaxel—ovarian cancer	3.57e-05	0.000845	CcSEcCtD
Topotecan—Anaphylactic shock—Paclitaxel—ovarian cancer	3.55e-05	0.000841	CcSEcCtD
Topotecan—Muscle spasms—Docetaxel—ovarian cancer	3.55e-05	0.00084	CcSEcCtD
Topotecan—Infection—Paclitaxel—ovarian cancer	3.53e-05	0.000836	CcSEcCtD
Topotecan—Dizziness—Vinorelbine—ovarian cancer	3.49e-05	0.000827	CcSEcCtD
Topotecan—Nervous system disorder—Paclitaxel—ovarian cancer	3.49e-05	0.000825	CcSEcCtD
Topotecan—Thrombocytopenia—Paclitaxel—ovarian cancer	3.48e-05	0.000823	CcSEcCtD
Topotecan—Skin disorder—Paclitaxel—ovarian cancer	3.45e-05	0.000817	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	3.44e-05	0.000815	CcSEcCtD
Topotecan—Hyperhidrosis—Paclitaxel—ovarian cancer	3.44e-05	0.000813	CcSEcCtD
Topotecan—Anaemia—Docetaxel—ovarian cancer	3.41e-05	0.000807	CcSEcCtD
Topotecan—Pancytopenia—Epirubicin—ovarian cancer	3.39e-05	0.000803	CcSEcCtD
Topotecan—Anorexia—Paclitaxel—ovarian cancer	3.39e-05	0.000802	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	3.37e-05	0.000798	CcSEcCtD
Topotecan—Vomiting—Vinorelbine—ovarian cancer	3.36e-05	0.000795	CcSEcCtD
Topotecan—Neutropenia—Epirubicin—ovarian cancer	3.34e-05	0.000791	CcSEcCtD
Topotecan—Rash—Vinorelbine—ovarian cancer	3.33e-05	0.000788	CcSEcCtD
Topotecan—Dermatitis—Vinorelbine—ovarian cancer	3.33e-05	0.000788	CcSEcCtD
Topotecan—Headache—Vinorelbine—ovarian cancer	3.31e-05	0.000783	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—ovarian cancer	3.3e-05	0.000782	CcSEcCtD
Topotecan—Weight increased—Epirubicin—ovarian cancer	3.25e-05	0.00077	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	3.24e-05	0.000766	CcSEcCtD
Topotecan—Cough—Docetaxel—ovarian cancer	3.22e-05	0.000762	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ovarian cancer	3.21e-05	0.0087	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	3.21e-05	0.00868	CbGpPWpGaD
Topotecan—Pneumonia—Epirubicin—ovarian cancer	3.2e-05	0.000758	CcSEcCtD
Topotecan—Paraesthesia—Paclitaxel—ovarian cancer	3.19e-05	0.000755	CcSEcCtD
Topotecan—Infestation—Epirubicin—ovarian cancer	3.19e-05	0.000754	CcSEcCtD
Topotecan—Infestation NOS—Epirubicin—ovarian cancer	3.19e-05	0.000754	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.18e-05	0.00862	CbGpPWpGaD
Topotecan—Dyspnoea—Paclitaxel—ovarian cancer	3.17e-05	0.00075	CcSEcCtD
Topotecan—Chest pain—Docetaxel—ovarian cancer	3.14e-05	0.000744	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—ovarian cancer	3.14e-05	0.000744	CcSEcCtD
Topotecan—Myalgia—Docetaxel—ovarian cancer	3.14e-05	0.000744	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—ovarian cancer	3.14e-05	0.000743	CcSEcCtD
Topotecan—Nausea—Vinorelbine—ovarian cancer	3.14e-05	0.000743	CcSEcCtD
Topotecan—Dyspepsia—Paclitaxel—ovarian cancer	3.13e-05	0.00074	CcSEcCtD
Topotecan—Neuropathy peripheral—Epirubicin—ovarian cancer	3.12e-05	0.000739	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	3.12e-05	0.000739	CcSEcCtD
Topotecan—Stomatitis—Epirubicin—ovarian cancer	3.11e-05	0.000735	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—ovarian cancer	3.09e-05	0.000732	CcSEcCtD
Topotecan—Decreased appetite—Paclitaxel—ovarian cancer	3.09e-05	0.000731	CcSEcCtD
Topotecan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	3.07e-05	0.000726	CcSEcCtD
Topotecan—Fatigue—Paclitaxel—ovarian cancer	3.06e-05	0.000725	CcSEcCtD
Topotecan—Sweating—Epirubicin—ovarian cancer	3.05e-05	0.000723	CcSEcCtD
Topotecan—Pain—Paclitaxel—ovarian cancer	3.04e-05	0.000719	CcSEcCtD
Topotecan—Constipation—Paclitaxel—ovarian cancer	3.04e-05	0.000719	CcSEcCtD
Topotecan—Hepatobiliary disease—Epirubicin—ovarian cancer	3.01e-05	0.000713	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—ovarian cancer	3.01e-05	0.000713	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—ovarian cancer	3.01e-05	0.000712	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—ovarian cancer	3.01e-05	0.000711	CcSEcCtD
Topotecan—Infection—Docetaxel—ovarian cancer	2.99e-05	0.000708	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—ovarian cancer	2.97e-05	0.000702	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—ovarian cancer	2.95e-05	0.000699	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—ovarian cancer	2.95e-05	0.000698	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.95e-05	0.00798	CbGpPWpGaD
Topotecan—Infestation NOS—Doxorubicin—ovarian cancer	2.95e-05	0.000698	CcSEcCtD
Topotecan—Infestation—Doxorubicin—ovarian cancer	2.95e-05	0.000698	CcSEcCtD
Topotecan—Feeling abnormal—Paclitaxel—ovarian cancer	2.93e-05	0.000693	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—ovarian cancer	2.93e-05	0.000692	CcSEcCtD
Topotecan—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.91e-05	0.000688	CcSEcCtD
Topotecan—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	2.9e-05	0.00784	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.89e-05	0.00782	CbGpPWpGaD
Topotecan—Neuropathy peripheral—Doxorubicin—ovarian cancer	2.89e-05	0.000684	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—ovarian cancer	2.87e-05	0.00068	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—ovarian cancer	2.87e-05	0.00068	CcSEcCtD
Topotecan—Anorexia—Docetaxel—ovarian cancer	2.87e-05	0.00068	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—ovarian cancer	2.87e-05	0.000679	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—ovarian cancer	2.86e-05	0.000677	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—ovarian cancer	2.85e-05	0.000673	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—ovarian cancer	2.84e-05	0.000672	CcSEcCtD
Topotecan—Sweating—Doxorubicin—ovarian cancer	2.83e-05	0.000669	CcSEcCtD
Topotecan—Urticaria—Paclitaxel—ovarian cancer	2.82e-05	0.000668	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.81e-05	0.00762	CbGpPWpGaD
Topotecan—Abdominal pain—Paclitaxel—ovarian cancer	2.81e-05	0.000665	CcSEcCtD
Topotecan—Body temperature increased—Paclitaxel—ovarian cancer	2.81e-05	0.000665	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.79e-05	0.00066	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.79e-05	0.00754	CbGpPWpGaD
Topotecan—Epistaxis—Doxorubicin—ovarian cancer	2.78e-05	0.000658	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.74e-05	0.000649	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.72e-05	0.00735	CbGpPWpGaD
Topotecan—Paraesthesia—Docetaxel—ovarian cancer	2.71e-05	0.00064	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—ovarian cancer	2.69e-05	0.000636	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—ovarian cancer	2.66e-05	0.000629	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—ovarian cancer	2.65e-05	0.000628	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—ovarian cancer	2.65e-05	0.000628	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—ovarian cancer	2.65e-05	0.000626	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—ovarian cancer	2.63e-05	0.000623	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—ovarian cancer	2.63e-05	0.000622	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—ovarian cancer	2.62e-05	0.00062	CcSEcCtD
Topotecan—Hypersensitivity—Paclitaxel—ovarian cancer	2.62e-05	0.00062	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—PTEN—ovarian cancer	2.61e-05	0.00706	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.6e-05	0.000615	CcSEcCtD
Topotecan—Fatigue—Docetaxel—ovarian cancer	2.6e-05	0.000615	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—ovarian cancer	2.59e-05	0.000614	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	2.59e-05	0.00701	CbGpPWpGaD
Topotecan—Immune system disorder—Epirubicin—ovarian cancer	2.58e-05	0.000611	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—ovarian cancer	2.58e-05	0.00061	CcSEcCtD
Topotecan—Constipation—Docetaxel—ovarian cancer	2.58e-05	0.00061	CcSEcCtD
Topotecan—Pain—Docetaxel—ovarian cancer	2.58e-05	0.00061	CcSEcCtD
Topotecan—Chills—Epirubicin—ovarian cancer	2.57e-05	0.000607	CcSEcCtD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	2.56e-05	0.00693	CbGpPWpGaD
Topotecan—Asthenia—Paclitaxel—ovarian cancer	2.55e-05	0.000603	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ABCB1—ovarian cancer	2.53e-05	0.00686	CbGpPWpGaD
Topotecan—Alopecia—Epirubicin—ovarian cancer	2.53e-05	0.000598	CcSEcCtD
Topotecan—Pruritus—Paclitaxel—ovarian cancer	2.51e-05	0.000595	CcSEcCtD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	2.5e-05	0.00676	CbGpPWpGaD
Topotecan—Malnutrition—Epirubicin—ovarian cancer	2.49e-05	0.000589	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—ovarian cancer	2.48e-05	0.000587	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—ovarian cancer	2.46e-05	0.000583	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.45e-05	0.00664	CbGpPWpGaD
Topotecan—Diarrhoea—Paclitaxel—ovarian cancer	2.43e-05	0.000575	CcSEcCtD
Topotecan—Back pain—Epirubicin—ovarian cancer	2.41e-05	0.00057	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—ovarian cancer	2.4e-05	0.000568	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—ovarian cancer	2.39e-05	0.000566	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—ovarian cancer	2.39e-05	0.000566	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—ovarian cancer	2.39e-05	0.000564	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—ovarian cancer	2.38e-05	0.000564	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—ovarian cancer	2.38e-05	0.000564	CcSEcCtD
Topotecan—Chills—Doxorubicin—ovarian cancer	2.37e-05	0.000562	CcSEcCtD
Topotecan—Dizziness—Paclitaxel—ovarian cancer	2.35e-05	0.000556	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—ovarian cancer	2.34e-05	0.000553	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.32e-05	0.00628	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	2.32e-05	0.00627	CbGpPWpGaD
Topotecan—Ill-defined disorder—Epirubicin—ovarian cancer	2.31e-05	0.000547	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—ovarian cancer	2.3e-05	0.000545	CcSEcCtD
Topotecan—Anaemia—Epirubicin—ovarian cancer	2.3e-05	0.000545	CcSEcCtD
Topotecan—Vomiting—Paclitaxel—ovarian cancer	2.26e-05	0.000535	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.26e-05	0.00611	CbGpPWpGaD
Topotecan—Malaise—Epirubicin—ovarian cancer	2.25e-05	0.000531	CcSEcCtD
Topotecan—Rash—Paclitaxel—ovarian cancer	2.24e-05	0.00053	CcSEcCtD
Topotecan—Dermatitis—Paclitaxel—ovarian cancer	2.24e-05	0.00053	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—ovarian cancer	2.23e-05	0.000527	CcSEcCtD
Topotecan—Back pain—Doxorubicin—ovarian cancer	2.23e-05	0.000527	CcSEcCtD
Topotecan—Headache—Paclitaxel—ovarian cancer	2.23e-05	0.000527	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—ovarian cancer	2.22e-05	0.000525	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—ovarian cancer	2.21e-05	0.000524	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.21e-05	0.00598	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.21e-05	0.00597	CbGpPWpGaD
Topotecan—Cough—Epirubicin—ovarian cancer	2.17e-05	0.000514	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TERT—ovarian cancer	2.17e-05	0.00587	CbGpPWpGaD
Topotecan—Asthenia—Docetaxel—ovarian cancer	2.16e-05	0.000511	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—ovarian cancer	2.14e-05	0.000506	CcSEcCtD
Topotecan—Pruritus—Docetaxel—ovarian cancer	2.13e-05	0.000504	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—ovarian cancer	2.13e-05	0.000504	CcSEcCtD
Topotecan—Chest pain—Epirubicin—ovarian cancer	2.12e-05	0.000502	CcSEcCtD
Topotecan—Myalgia—Epirubicin—ovarian cancer	2.12e-05	0.000502	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—ovarian cancer	2.12e-05	0.000502	CcSEcCtD
Topotecan—Nausea—Paclitaxel—ovarian cancer	2.11e-05	0.0005	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	2.11e-05	0.000498	CcSEcCtD
Topotecan—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	2.1e-05	0.00569	CbGpPWpGaD
Topotecan—Discomfort—Epirubicin—ovarian cancer	2.09e-05	0.000496	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.09e-05	0.00564	CbGpPWpGaD
Topotecan—Malaise—Doxorubicin—ovarian cancer	2.08e-05	0.000492	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—ovarian cancer	2.06e-05	0.000488	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—ovarian cancer	2.06e-05	0.000488	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—ovarian cancer	2.03e-05	0.000481	CcSEcCtD
Topotecan—Infection—Epirubicin—ovarian cancer	2.02e-05	0.000478	CcSEcCtD
Topotecan—Cough—Doxorubicin—ovarian cancer	2.01e-05	0.000476	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	2e-05	0.00542	CbGpPWpGaD
Topotecan—Nervous system disorder—Epirubicin—ovarian cancer	1.99e-05	0.000472	CcSEcCtD
Topotecan—Dizziness—Docetaxel—ovarian cancer	1.99e-05	0.000471	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—ovarian cancer	1.99e-05	0.000471	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—ovarian cancer	1.97e-05	0.000467	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—ovarian cancer	1.96e-05	0.000465	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—ovarian cancer	1.96e-05	0.000464	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—ovarian cancer	1.96e-05	0.000464	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—ovarian cancer	1.96e-05	0.000464	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.95e-05	0.000461	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—ovarian cancer	1.94e-05	0.000459	CcSEcCtD
Topotecan—Anorexia—Epirubicin—ovarian cancer	1.94e-05	0.000458	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.92e-05	0.00519	CbGpPWpGaD
Topotecan—Vomiting—Docetaxel—ovarian cancer	1.92e-05	0.000453	CcSEcCtD
Topotecan—Rash—Docetaxel—ovarian cancer	1.9e-05	0.000449	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—ovarian cancer	1.9e-05	0.000449	CcSEcCtD
Topotecan—Headache—Docetaxel—ovarian cancer	1.89e-05	0.000447	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—ovarian cancer	1.88e-05	0.000445	CcSEcCtD
Topotecan—Infection—Doxorubicin—ovarian cancer	1.87e-05	0.000442	CcSEcCtD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—ovarian cancer	1.86e-05	0.00502	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.85e-05	0.00502	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.85e-05	0.000438	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—ovarian cancer	1.84e-05	0.000436	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—ovarian cancer	1.84e-05	0.000436	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—ovarian cancer	1.83e-05	0.000432	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—ovarian cancer	1.82e-05	0.000432	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—ovarian cancer	1.82e-05	0.00043	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—ovarian cancer	1.81e-05	0.000429	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—ovarian cancer	1.79e-05	0.000424	CcSEcCtD
Topotecan—Nausea—Docetaxel—ovarian cancer	1.79e-05	0.000423	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—ovarian cancer	1.79e-05	0.000423	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TP53—ovarian cancer	1.78e-05	0.00482	CbGpPWpGaD
Topotecan—Decreased appetite—Epirubicin—ovarian cancer	1.77e-05	0.000418	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.75e-05	0.000415	CcSEcCtD
Topotecan—Fatigue—Epirubicin—ovarian cancer	1.75e-05	0.000415	CcSEcCtD
Topotecan—Constipation—Epirubicin—ovarian cancer	1.74e-05	0.000411	CcSEcCtD
Topotecan—Pain—Epirubicin—ovarian cancer	1.74e-05	0.000411	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	1.73e-05	0.0047	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.71e-05	0.000405	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—ovarian cancer	1.69e-05	0.000399	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—ovarian cancer	1.68e-05	0.000397	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—ovarian cancer	1.67e-05	0.000396	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	1.67e-05	0.00451	CbGpPWpGaD
Topotecan—Gastrointestinal pain—Epirubicin—ovarian cancer	1.66e-05	0.000393	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—ovarian cancer	1.66e-05	0.000392	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—ovarian cancer	1.63e-05	0.000387	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	1.63e-05	0.00442	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—ovarian cancer	1.63e-05	0.00441	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.62e-05	0.000384	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—ovarian cancer	1.62e-05	0.000384	CcSEcCtD
Topotecan—Urticaria—Epirubicin—ovarian cancer	1.61e-05	0.000382	CcSEcCtD
Topotecan—Constipation—Doxorubicin—ovarian cancer	1.61e-05	0.00038	CcSEcCtD
Topotecan—Pain—Doxorubicin—ovarian cancer	1.61e-05	0.00038	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—ovarian cancer	1.61e-05	0.00038	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—ovarian cancer	1.61e-05	0.00038	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.57e-05	0.00424	CbGpPWpGaD
Topotecan—Feeling abnormal—Doxorubicin—ovarian cancer	1.55e-05	0.000367	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.54e-05	0.000364	CcSEcCtD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.51e-05	0.00408	CbGpPWpGaD
Topotecan—Hypersensitivity—Epirubicin—ovarian cancer	1.5e-05	0.000354	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—ovarian cancer	1.49e-05	0.000353	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—ovarian cancer	1.49e-05	0.000352	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—ovarian cancer	1.49e-05	0.000352	CcSEcCtD
Topotecan—Asthenia—Epirubicin—ovarian cancer	1.46e-05	0.000345	CcSEcCtD
Topotecan—Pruritus—Epirubicin—ovarian cancer	1.44e-05	0.00034	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—ovarian cancer	1.44e-05	0.00389	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	1.43e-05	0.00388	CbGpPWpGaD
Topotecan—Diarrhoea—Epirubicin—ovarian cancer	1.39e-05	0.000329	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—ovarian cancer	1.39e-05	0.000328	CcSEcCtD
Topotecan—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	1.37e-05	0.0037	CbGpPWpGaD
Topotecan—Asthenia—Doxorubicin—ovarian cancer	1.35e-05	0.000319	CcSEcCtD
Topotecan—Dizziness—Epirubicin—ovarian cancer	1.34e-05	0.000318	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—ovarian cancer	1.33e-05	0.000315	CcSEcCtD
Topotecan—Vomiting—Epirubicin—ovarian cancer	1.29e-05	0.000306	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—ovarian cancer	1.29e-05	0.000304	CcSEcCtD
Topotecan—Rash—Epirubicin—ovarian cancer	1.28e-05	0.000303	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—ovarian cancer	1.28e-05	0.000303	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	1.28e-05	0.00345	CbGpPWpGaD
Topotecan—Headache—Epirubicin—ovarian cancer	1.27e-05	0.000301	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—ovarian cancer	1.24e-05	0.000294	CcSEcCtD
Topotecan—Nausea—Epirubicin—ovarian cancer	1.21e-05	0.000286	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—ovarian cancer	1.2e-05	0.000283	CcSEcCtD
Topotecan—Rash—Doxorubicin—ovarian cancer	1.19e-05	0.000281	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—ovarian cancer	1.18e-05	0.00028	CcSEcCtD
Topotecan—Headache—Doxorubicin—ovarian cancer	1.18e-05	0.000279	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	1.17e-05	0.00317	CbGpPWpGaD
Topotecan—Nausea—Doxorubicin—ovarian cancer	1.12e-05	0.000264	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.11e-05	0.00302	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.11e-05	0.00299	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.09e-05	0.00296	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.09e-05	0.00295	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.07e-05	0.00289	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	9.01e-06	0.00244	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	8.96e-06	0.00243	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NME2—ovarian cancer	8.72e-06	0.00236	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.45e-06	0.00229	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	7.8e-06	0.00211	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	7.13e-06	0.00193	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	6.97e-06	0.00189	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	6.89e-06	0.00187	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	6.68e-06	0.00181	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	6.3e-06	0.0017	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	6.04e-06	0.00164	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.03e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—ovarian cancer	6.03e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2—ovarian cancer	6.02e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	5.9e-06	0.0016	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	5.85e-06	0.00158	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.78e-06	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	5.75e-06	0.00156	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.64e-06	0.00153	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYTB—ovarian cancer	5.62e-06	0.00152	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.44e-06	0.00147	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	5.11e-06	0.00138	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP1CC—ovarian cancer	4.91e-06	0.00133	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BRIP1—ovarian cancer	4.91e-06	0.00133	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.76e-06	0.00129	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NME2—ovarian cancer	4.71e-06	0.00128	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.7e-06	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.57e-06	0.00124	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4.46e-06	0.00121	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.3e-06	0.00116	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	4.22e-06	0.00114	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.77e-06	0.00102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—YAP1—ovarian cancer	3.29e-06	0.000891	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.28e-06	0.000887	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.05e-06	0.000825	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYTB—ovarian cancer	3.04e-06	0.000822	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.03e-06	0.000821	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.97e-06	0.000805	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.94e-06	0.000797	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NME2—ovarian cancer	2.9e-06	0.000786	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.89e-06	0.000783	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.87e-06	0.000776	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.79e-06	0.000756	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FASN—ovarian cancer	2.68e-06	0.000727	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BRIP1—ovarian cancer	2.65e-06	0.000718	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP1CC—ovarian cancer	2.65e-06	0.000718	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC5A5—ovarian cancer	2.64e-06	0.000715	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A1—ovarian cancer	2.55e-06	0.00069	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.52e-06	0.000683	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1B1—ovarian cancer	2.44e-06	0.000662	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.39e-06	0.000646	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.32e-06	0.000628	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.27e-06	0.000615	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.27e-06	0.000615	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP2R1A—ovarian cancer	2.17e-06	0.000587	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.15e-06	0.000581	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—ovarian cancer	2.01e-06	0.000545	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—ovarian cancer	1.98e-06	0.000535	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.97e-06	0.000533	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.91e-06	0.000516	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYTB—ovarian cancer	1.87e-06	0.000506	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—YAP1—ovarian cancer	1.78e-06	0.000482	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.64e-06	0.000443	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.64e-06	0.000443	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.61e-06	0.000436	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—ovarian cancer	1.59e-06	0.000431	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.45e-06	0.000393	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FASN—ovarian cancer	1.45e-06	0.000393	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.43e-06	0.000386	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.38e-06	0.000373	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.32e-06	0.000358	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—ovarian cancer	1.28e-06	0.000345	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.17e-06	0.000317	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—ovarian cancer	1.11e-06	0.000301	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—YAP1—ovarian cancer	1.1e-06	0.000297	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—ovarian cancer	1.07e-06	0.000289	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—ovarian cancer	9.61e-07	0.00026	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FASN—ovarian cancer	8.94e-07	0.000242	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A5—ovarian cancer	8.79e-07	0.000238	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—ovarian cancer	8.61e-07	0.000233	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A1—ovarian cancer	8.49e-07	0.00023	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1B1—ovarian cancer	8.14e-07	0.00022	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—ovarian cancer	7.85e-07	0.000212	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	7.22e-07	0.000195	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—ovarian cancer	6.9e-07	0.000187	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—ovarian cancer	6.78e-07	0.000183	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.71e-07	0.000182	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—ovarian cancer	6.59e-07	0.000178	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—ovarian cancer	6.01e-07	0.000163	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—ovarian cancer	5.54e-07	0.00015	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—ovarian cancer	5.31e-07	0.000144	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—ovarian cancer	5.2e-07	0.000141	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.83e-07	0.000131	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.25e-07	0.000115	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.7e-07	0.0001	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.67e-07	9.92e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—ovarian cancer	3.2e-07	8.66e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—ovarian cancer	2.99e-07	8.1e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.26e-07	6.11e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—ovarian cancer	1.84e-07	4.99e-05	CbGpPWpGaD
